600285 羚銳製藥
按盤價 
20.470 -2.080 (-9.224%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 14.930 | 23.466 | 24.645 | 21.270 | 19.268 |
| 總資產報酬率 ROA (%) | 8.693 | 14.260 | 14.763 | 12.463 | 11.436 |
| 投入資產回報率 ROIC (%) | 12.968 | 21.150 | 22.823 | 19.204 | 17.403 | 邊際利潤分析 |
| 銷售毛利率 (%) | 78.899 | 80.029 | 75.818 | 73.293 | 72.280 |
| 營業利潤率 (%) | 26.949 | 23.026 | 23.146 | 19.819 | 17.227 |
| 息稅前利潤/營業總收入 (%) | 26.544 | 22.691 | 23.100 | 18.660 | 16.338 |
| 淨利潤/營業總收入 (%) | 23.178 | 19.786 | 20.640 | 17.156 | 15.501 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 96.852 | 93.661 | 88.534 | 96.191 | 80.738 |
| 價值變動淨收益/利潤總額(%) | 4.201 | 4.852 | 4.858 | 3.105 | 12.491 |
| 營業外收支淨額/利潤總額(%) | -0.269 | -0.888 | 2.087 | -0.500 | -0.017 | 償債能力分析 |
| 流動比率 (X) | 1.179 | 1.078 | 1.311 | 1.368 | 1.465 |
| 速動比率 (X) | 1.029 | 0.871 | 1.079 | 1.122 | 1.181 |
| 資產負債率 (%) | 43.190 | 39.031 | 38.601 | 41.351 | 41.114 |
| 帶息債務/全部投入資本 (%) | 10.648 | 11.367 | 3.566 | 7.043 | 7.415 |
| 股東權益/帶息債務 (%) | 819.347 | 760.963 | 2,650.278 | 1,286.206 | 1,213.334 |
| 股東權益/負債合計 (%) | 130.001 | 154.601 | 158.660 | 141.446 | 142.802 |
| 利息保障倍數 (X) | -79.699 | -171.772 | -42.821 | -17.595 | -18.446 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 43.479 | 35.023 | 29.707 | 24.698 | 22.119 |
| 存貨周轉天數 (天) | 158.007 | 203.872 | 191.857 | 194.120 | 197.887 |
| 備註： | 即時報價更新時間為 12/08/2026 15:31 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
